AG-01(Ache Laboratories)

N/A

Report date: 2022/12/08 16:46:04
NME

Base Information

Drug NameAG-01(Ache Laboratories)
Drug Alias NamePDI-41AG-01(Ache Laboratories)
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAche Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesAche Laboratories
Inactive CompaniesN/A
Active IndicationsAtherosclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A